MOG and myeloid sarcoma: Nevertheless, it is important to note that we observed a significant difference in anti-MOG1-125 committed B cells between the MS patients and the controls (P = 0.018), whereas no difference in anti-MOG antibody titers against conformational and linear MOG has been found [40] in adult MS patients, clearly suggesting a B cell specific alteration in this disease.